Genous TM endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study.
Phase of Trial: Phase III
Latest Information Update: 17 Sep 2014
At a glance
- Drugs Anti-CD34 monoclonal antibody (Primary) ; Paclitaxel
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms TRIAS-HR-pilot
- 16 Aug 2011 Two-year follow-up results published in Catheterization and Cardiovascular Interventions, according to an OrbusNeich media release.
- 05 Nov 2010 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History